144 related articles for article (PubMed ID: 22095489)
1. A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.
Guarnieri V; Baorda F; Battista C; Bisceglia M; Balsamo T; Gruppioni E; Fiorentino M; Muscarella LA; Coco M; Barbano R; Corbetta S; Spada A; Cole DE; Canaff L; Hendy GN; Carella M; Scillitani A
Endocrine; 2012 Feb; 41(1):152-5. PubMed ID: 22095489
[No Abstract] [Full Text] [Related]
2. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T
Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020
[TBL] [Abstract][Full Text] [Related]
3. Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas.
Haglund F; Andreasson A; Nilsson IL; Höög A; Larsson C; Juhlin CC
Clin Endocrinol (Oxf); 2010 Oct; 73(4):552-3. PubMed ID: 20550535
[No Abstract] [Full Text] [Related]
4. Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2007 Apr; 92(4):1564-6. PubMed ID: 17284619
[TBL] [Abstract][Full Text] [Related]
5. Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.
Björklund P; Lindberg D; Akerström G; Westin G
Mol Cancer; 2008 Jun; 7():53. PubMed ID: 18541010
[TBL] [Abstract][Full Text] [Related]
6. Ruling out a suspect: the role of beta-catenin mutation in benign parathyroid neoplasia.
Simonds WF
J Clin Endocrinol Metab; 2007 Apr; 92(4):1235-6. PubMed ID: 17409343
[No Abstract] [Full Text] [Related]
7. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
[TBL] [Abstract][Full Text] [Related]
8. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
[TBL] [Abstract][Full Text] [Related]
9. Familial hyperparathyroidism. Medical and surgical considerations.
Graber AL; Jacobs K
JAMA; 1968 May; 204(6):542-4. PubMed ID: 5694438
[No Abstract] [Full Text] [Related]
10. Familial hyperparathyroidism.
Sandler LM; Moncrieff MW
Arch Dis Child; 1980 Feb; 55(2):146-7. PubMed ID: 7377835
[TBL] [Abstract][Full Text] [Related]
11. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
12. [Familial primary hyperparathyroidism--parathyroid adenoma in sisters].
Shimura H; Mihara A; Hashizume Y
Nihon Rinsho; 1972 Mar; 30(3):838-44. PubMed ID: 5064552
[No Abstract] [Full Text] [Related]
13. Familial hyperparathyroidism.
Stevens LE; Bloomer HA; Castleton KB
Arch Surg; 1967 Apr; 94(4):524-31. PubMed ID: 6021148
[No Abstract] [Full Text] [Related]
14. Familial multiple endocrine adenopathy (primary hyperparathyroidism and Zollinger-Ellison syndrome) in two siblings.
Dutta P; Wallace MR; Wrong OM; Taylor S; Welbourn RB
Proc R Soc Med; 1968 Jul; 61(7):658-60. PubMed ID: 4298825
[No Abstract] [Full Text] [Related]
15. Jaw lesions in familial hyperparathyroidism.
Kennett S; Pollick H
Oral Surg Oral Med Oral Pathol; 1971 Apr; 31(4):502-10. PubMed ID: 5279024
[No Abstract] [Full Text] [Related]
16. [Clinical and morphological characteristics of parathyroid carcinoma].
Voronkova IA; Mokrysheva NG; Kazantseva IA; Gurevich LE
Arkh Patol; 2018; 80(4):65-72. PubMed ID: 30059074
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.
Guarnieri V; Scillitani A; Muscarella LA; Battista C; Bonfitto N; Bisceglia M; Minisola S; Mascia ML; D'Agruma L; Cole DE
J Clin Endocrinol Metab; 2006 Aug; 91(8):2827-32. PubMed ID: 16720667
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid cyst and hyperparathyroidism in Auckland.
Koea JB; Shaw JH
N Z Med J; 1988 Oct; 101(856 Pt 1):655-6. PubMed ID: 3186002
[TBL] [Abstract][Full Text] [Related]
19. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of hyperparathyroid disease.
Tominaga Y; Takagi H
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):336-41. PubMed ID: 8823531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
